ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 164 out of 3734

$1.15M Total Retail Price of All Prescriptions

Rank: 60 out of 3734

789 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 789 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 789 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,967 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 582 408 1 1
LEVOTHYROXINE SODIUM 555 407 2 2
OXYCODONE HCL 436 103 S2 3 58
LISINOPRIL 387 295 4 3
HYDROCODONE-ACETAMINOPHEN 380 279 S3 5 12
OMEPRAZOLE 359 282 6 4
AMLODIPINE BESYLATE 319 254 7 5
FUROSEMIDE 294 233 8 7
AZITHROMYCIN 262 147 9 38
ZOLPIDEM TARTRATE 248 142 10 24
ENDOCET 236 84 S2 11 89
HYDROCHLOROTHIAZIDE 229 154 12 9
METOPROLOL TARTRATE 228 164 13 6
PRAVASTATIN SODIUM 225 175 14 15
METFORMIN HCL 222 197 15 8
NEXIUM 207 116 16 36
SERTRALINE HCL 204 146 17 18
LOSARTAN POTASSIUM 187 170 18 21
AMOXICILLIN 185 103 19 108
OXYCONTIN 184 28 S2 20 121
OXYCODONE-ACETAMINOPHEN 169 94 S2 21 51
OXYCODONE HCL-ACETAMINOPHEN 155 49 S2 22 122
IBUPROFEN 149 57 23 75
DIOVAN 145 120 24 31
METOPROLOL SUCCINATE 143 104 25 14
RANITIDINE HCL 140 95 26 32
ATORVASTATIN CALCIUM 139 110 27 11
POTASSIUM CHLORIDE 128 62 28 19
CITALOPRAM HBR 122 68 29 16
ISOSORBIDE MONONITRATE ER 115 78 30 34
VENTOLIN HFA 113 49 31 70
TRAMADOL HCL 111 68 32 20
FLUOXETINE HCL 105 44 33 61
PANTOPRAZOLE SODIUM 102 75 34 22
CIPROFLOXACIN HCL 101 77 35 77
CLOPIDOGREL 97 71 36 23
CARISOPRODOL 95 0 R 37 134
ADVAIR DISKUS 89 68 38 35
PREDNISONE 87 63 39 42
PROAIR HFA 87 47 39 83
FLUTICASONE PROPIONATE 87 51 39 46
LOVASTATIN 86 82 42 41
ATENOLOL 86 84 42 13
LOSARTAN-HYDROCHLOROTHIAZIDE 83 75 44 71
GLIPIZIDE XL 83 82 44 85
PAROXETINE HCL 82 79 46 59
TAMSULOSIN HCL 81 65 47 29
WARFARIN SODIUM 80 49 48 10
GLIPIZIDE 79 52 49 57
SPIRIVA 77 62 50 40
GLIPIZIDE ER 74 45 51 119
LEVOFLOXACIN 72 54 52 116
DIPHENOXYLATE-ATROPINE 72 42 52 289
GABAPENTIN 69 24 54 17
JANUVIA 67 32 55 50
LOVAZA 67 42 55 143
METHYLPREDNISOLONE 67 39 55 133
CARVEDILOL 67 45 55 30
RAMIPRIL 67 67 55 91
CELEBREX 67 50 55 69
ESCITALOPRAM OXALATE 67 49 55 68
NAPROXEN 66 45 62 101
TRAZODONE HCL 66 36 62 49
ALLOPURINOL 66 49 62 33
CRESTOR 65 47 65 28
SYNTHROID 63 50 66 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 55 67 27
COMBIVENT 62 49 67 156
VERAPAMIL ER 62 47 67 96
ENALAPRIL MALEATE 61 59 70 63
VENLAFAXINE HCL ER 60 22 71 84
DONEPEZIL HCL 59 59 72 25
KLOR-CON 10 58 33 73 140
SINGULAIR 57 19 74 95
CEPHALEXIN 57 34 74 120
LIDODERM 56 39 76 170
FAMOTIDINE 53 33 77 60
SPIRONOLACTONE 52 30 78 80
BISOPROLOL-HYDROCHLOROTHIAZIDE 51 41 79 145
FINASTERIDE 51 41 79 88
GLIMEPIRIDE 50 50 81 37
CYCLOBENZAPRINE HCL 50 0 R 81 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.